O	0	1	N	N	NN	B-NP
O	1	2	-	-	HYPH	I-NP
O	2	8	methyl	methyl	NN	I-NP
O	8	9	-	-	HYPH	B-NP
O	9	10	N	N	NN	I-NP
O	10	11	-	-	HYPH	B-NP
O	11	22	nitrosourea	nitrosourea	NN	I-NP
O	22	23	-	-	HYPH	O
O	23	30	induced	induce	VBN	B-NP
O	31	45	transformation	transformation	NN	I-NP
O	46	48	of	of	IN	B-PP
O	49	52	rat	rat	NN	B-NP
B-Cell	53	63	urothelial	urothelial	JJ	I-NP
I-Cell	64	69	cells	cell	NNS	I-NP
O	70	72	in	in	FW	B-PP
O	73	78	vitro	vitro	FW	B-NP
O	79	81	is	be	VBZ	B-VP
O	82	85	not	not	RB	I-VP
O	86	94	mediated	mediate	VBN	I-VP
O	95	97	by	by	IN	B-PP
O	98	108	activation	activation	NN	B-NP
O	109	111	of	of	IN	B-PP
O	112	115	ras	ras	NN	B-NP
O	116	125	oncogenes	oncogene	NNS	I-NP
O	125	126	.	.	.	O

O	128	133	Adult	Adult	JJ	B-NP
O	134	137	rat	rat	NN	I-NP
B-Cell	138	148	urothelial	urothelial	JJ	I-NP
I-Cell	149	154	cells	cell	NNS	I-NP
O	155	159	were	be	VBD	B-VP
O	160	171	transformed	transform	VBN	I-VP
O	172	174	in	in	FW	B-ADVP
O	175	180	vitro	vitro	FW	I-ADVP
O	181	190	following	follow	VBG	B-PP
O	191	200	treatment	treatment	NN	B-NP
O	201	205	with	with	IN	B-PP
O	206	207	a	a	DT	B-NP
O	208	214	single	single	JJ	I-NP
O	215	219	dose	dose	NN	I-NP
O	220	222	of	of	IN	B-PP
O	223	224	N	N	NN	B-NP
O	224	225	-	-	HYPH	B-NP
O	225	231	methyl	methyl	NN	I-NP
O	231	232	-	-	HYPH	B-NP
O	232	233	N	N	NN	I-NP
O	233	234	-	-	HYPH	O
O	234	245	nitrosourea	nitrosourea	NN	B-NP
O	246	247	(	(	(	O
O	247	250	MNU	MNU	NN	B-NP
O	250	251	)	)	)	O
O	252	254	or	or	CC	O
O	255	258	MNU	MNU	NN	B-NP
O	259	268	treatment	treatment	NN	I-NP
O	269	277	followed	follow	VBN	B-VP
O	278	280	by	by	IN	B-PP
O	281	290	promotion	promotion	NN	B-NP
O	291	295	with	with	IN	B-PP
O	296	302	sodium	sodium	NN	B-NP
O	303	312	saccharin	saccharin	NN	I-NP
O	312	313	.	.	.	O

O	314	318	This	This	DT	B-NP
O	319	321	in	in	FW	I-NP
O	322	327	vitro	vitro	FW	I-NP
O	328	342	transformation	transformation	NN	I-NP
O	343	350	process	process	NN	I-NP
O	351	359	involves	involve	VBZ	B-VP
O	360	368	multiple	multiple	JJ	B-NP
O	369	374	steps	step	NNS	I-NP
O	374	375	:	:	:	O
O	376	380	slow	slow	JJ	B-ADJP
O	380	381	-	-	HYPH	O
O	381	388	growing	grow	VBG	B-VP
B-Cell	389	390	'	'	''	O
I-Cell	390	393	pre	pre	AFX	B-NP
I-Cell	393	394	-	-	HYPH	I-NP
I-Cell	394	404	neoplastic	neoplastic	JJ	I-NP
I-Cell	404	405	'	'	''	I-NP
I-Cell	406	416	epithelial	epithelial	JJ	I-NP
I-Cell	417	421	foci	focus	NNS	I-NP
O	422	425	are	be	VBP	B-VP
O	426	433	induced	induce	VBN	I-VP
O	434	436	70	70	CD	B-NP
O	436	437	-	-	HYPH	I-NP
O	437	440	100	100	CD	I-NP
O	441	445	days	day	NNS	I-NP
O	446	451	after	after	IN	B-PP
O	452	455	MNU	MNU	NN	B-NP
O	456	465	treatment	treatment	NN	I-NP
O	466	469	and	and	CC	B-PP
O	470	474	from	from	IN	B-PP
O	475	479	such	such	JJ	B-NP
B-Cell	480	484	foci	focus	NNS	I-NP
O	485	492	rapidly	rapidly	RB	B-VP
O	493	506	proliferating	proliferate	VBG	I-VP
O	507	515	immortal	immortal	JJ	B-NP
B-Cell	516	520	cell	cell	NN	I-NP
I-Cell	521	526	lines	line	NNS	I-NP
O	527	531	were	be	VBD	B-VP
O	532	543	established	establish	VBN	I-VP
O	543	544	,	,	,	O
O	545	549	some	some	DT	B-NP
O	550	552	of	of	IN	B-PP
O	553	558	which	which	WDT	B-NP
O	559	565	became	become	VBD	B-VP
O	566	577	tumorigenic	tumorigenic	JJ	B-ADJP
O	578	583	after	after	IN	B-PP
O	584	585	a	a	DT	B-NP
O	586	593	further	further	JJ	I-NP
O	594	600	latent	latent	JJ	I-NP
O	601	607	period	period	NN	I-NP
O	607	608	.	.	.	O

O	609	610	A	A	DT	B-NP
O	611	617	series	series	NN	I-NP
O	618	620	of	of	IN	B-PP
B-Cell	621	631	epithelial	epithelial	JJ	B-NP
I-Cell	632	636	cell	cell	NN	I-NP
I-Cell	637	642	lines	line	NNS	I-NP
O	643	646	and	and	CC	O
O	647	648	a	a	DT	B-NP
O	649	655	single	single	JJ	I-NP
B-Cell	656	666	fibroblast	fibroblast	NN	I-NP
I-Cell	667	671	cell	cell	NN	I-NP
I-Cell	672	676	line	line	NN	I-NP
O	677	688	established	establish	VBN	B-VP
O	689	691	in	in	IN	B-PP
O	692	696	this	this	DT	B-NP
O	697	700	way	way	NN	I-NP
O	701	705	were	be	VBD	B-VP
O	706	714	analysed	analyse	VBN	I-VP
O	715	718	for	for	IN	B-PP
O	719	722	the	the	DT	B-NP
O	723	731	presence	presence	NN	I-NP
O	732	734	of	of	IN	B-PP
O	735	747	transforming	transform	VBG	B-VP
O	748	753	genes	gene	NNS	B-NP
O	754	756	by	by	IN	B-PP
O	757	760	DNA	DNA	NN	B-NP
O	761	773	transfection	transfection	NN	I-NP
O	774	778	into	into	IN	B-PP
B-Cell	779	785	NIH3T3	NIH3T3	NN	B-NP
I-Cell	786	791	cells	cell	NNS	I-NP
O	791	792	.	.	.	O

O	793	797	None	None	NN	B-NP
O	798	800	of	of	IN	B-PP
O	801	804	the	the	DT	B-NP
B-Cell	805	815	epithelial	epithelial	JJ	I-NP
I-Cell	816	820	cell	cell	NN	I-NP
I-Cell	821	826	lines	line	NNS	I-NP
O	827	834	induced	induce	VBD	B-VP
B-Cell	835	839	foci	focus	NNS	B-NP
O	840	842	in	in	IN	B-PP
O	843	844	a	a	DT	B-NP
B-Cell	845	850	focus	focus	NN	I-NP
O	851	860	formation	formation	NN	I-NP
O	861	866	assay	assay	NN	I-NP
O	866	867	.	.	.	O

O	868	871	The	The	DT	B-NP
O	872	878	single	single	JJ	I-NP
B-Cell	879	882	non	non	AFX	I-NP
I-Cell	882	883	-	-	HYPH	I-NP
I-Cell	883	893	epithelial	epithelial	JJ	I-NP
I-Cell	894	898	line	line	NN	I-NP
O	899	906	induced	induce	VBD	B-VP
B-Cell	907	911	foci	focus	NNS	B-NP
O	912	915	and	and	CC	O
O	916	919	was	be	VBD	B-VP
O	920	925	found	find	VBN	I-VP
O	926	928	to	to	TO	I-VP
O	929	936	contain	contain	VB	I-VP
O	937	939	an	an	DT	B-NP
O	940	949	activated	activate	VBN	I-NP
O	950	951	c	c	NN	I-NP
O	951	952	-	-	HYPH	I-NP
O	952	954	Ki	Ki	NN	I-NP
O	954	955	-	-	HYPH	I-NP
O	955	958	ras	ras	NN	I-NP
O	959	963	gene	gene	NN	I-NP
O	964	968	with	with	IN	B-PP
O	969	970	a	a	DT	B-NP
O	971	972	G	G	NN	I-NP
O	972	973	-	-	SYM	B-NP
O	973	974	-	-	SYM	B-NP
O	974	975	-	-	SYM	I-NP
O	975	976	-	-	HYPH	I-NP
O	976	977	A	A	NN	I-NP
O	978	988	transition	transition	NN	I-NP
O	989	991	in	in	IN	B-PP
O	992	997	codon	codon	NN	B-NP
O	998	1000	12	12	CD	I-NP
O	1000	1001	.	.	.	O

O	1002	1004	To	To	TO	B-VP
O	1005	1010	assay	assay	VB	I-VP
O	1011	1014	for	for	IN	B-PP
O	1015	1018	the	the	DT	B-NP
O	1019	1027	possible	possible	JJ	I-NP
O	1028	1036	presence	presence	NN	I-NP
O	1037	1039	of	of	IN	B-PP
O	1040	1052	transforming	transform	VBG	B-VP
O	1053	1058	genes	gene	NNS	B-NP
O	1059	1064	which	which	WDT	B-NP
O	1065	1069	were	be	VBD	B-VP
O	1070	1073	not	not	RB	O
O	1074	1080	active	active	JJ	B-ADJP
O	1081	1083	in	in	IN	B-PP
O	1084	1085	a	a	DT	B-NP
B-Cell	1086	1091	focus	focus	NN	I-NP
O	1092	1101	formation	formation	NN	I-NP
O	1102	1107	assay	assay	NN	I-NP
O	1107	1108	,	,	,	O
O	1109	1112	two	two	CD	B-NP
O	1113	1115	of	of	IN	B-PP
O	1116	1119	the	the	DT	B-NP
B-Cell	1120	1130	epithelial	epithelial	JJ	I-NP
I-Cell	1131	1136	lines	line	NNS	I-NP
O	1137	1141	were	be	VBD	B-VP
O	1142	1150	analysed	analyse	VBN	I-VP
O	1151	1158	further	further	RB	B-ADVP
O	1159	1161	by	by	IN	B-PP
O	1162	1164	co	co	AFX	B-NP
O	1164	1165	-	-	HYPH	I-NP
O	1165	1177	transfection	transfection	NN	I-NP
O	1178	1182	with	with	IN	B-PP
O	1183	1184	a	a	DT	B-NP
O	1185	1193	dominant	dominant	JJ	I-NP
O	1194	1204	selectable	selectable	JJ	I-NP
O	1205	1211	marker	marker	NN	I-NP
O	1211	1212	,	,	,	O
O	1213	1221	followed	follow	VBN	B-VP
O	1222	1224	by	by	IN	B-PP
O	1225	1234	selection	selection	NN	B-NP
O	1235	1238	and	and	CC	I-NP
O	1239	1250	inoculation	inoculation	NN	I-NP
O	1251	1255	into	into	IN	B-PP
O	1256	1260	nude	nude	JJ	B-NP
O	1261	1265	mice	mouse	NNS	I-NP
O	1265	1266	.	.	.	O

O	1267	1269	No	No	DT	B-NP
B-Cancer	1270	1277	tumours	tumour	NNS	I-NP
O	1278	1282	were	be	VBD	B-VP
O	1283	1290	induced	induce	VBN	I-VP
O	1291	1297	within	within	IN	B-PP
O	1298	1301	the	the	DT	B-NP
O	1302	1308	latent	latent	JJ	I-NP
O	1309	1315	period	period	NN	I-NP
O	1316	1319	for	for	IN	B-PP
B-Cancer	1320	1326	tumour	tumour	NN	B-NP
O	1327	1337	production	production	NN	I-NP
O	1338	1340	by	by	IN	B-PP
O	1341	1348	control	control	NN	B-NP
B-Cell	1349	1354	cells	cell	NNS	I-NP
O	1355	1366	transfected	transfecte	VBN	B-VP
O	1367	1371	with	with	IN	B-PP
B-Cell	1372	1378	NIH3T3	NIH3T3	NN	B-NP
I-Cell	1379	1383	cell	cell	NN	I-NP
O	1384	1387	DNA	DNA	NN	I-NP
O	1388	1389	(	(	(	O
O	1389	1391	40	40	CD	B-NP
O	1391	1392	-	-	HYPH	I-NP
O	1392	1394	60	60	CD	I-NP
O	1395	1399	days	day	NNS	I-NP
O	1399	1400	)	)	)	O
O	1400	1401	.	.	.	O

O	1402	1407	These	These	DT	B-NP
O	1408	1415	results	result	NNS	I-NP
O	1416	1423	suggest	suggest	VBP	B-VP
O	1424	1428	that	that	IN	B-SBAR
O	1429	1434	there	there	EX	B-NP
O	1435	1437	is	be	VBZ	B-VP
B-Cell	1438	1442	cell	cell	NN	B-NP
O	1443	1447	type	type	NN	I-NP
O	1448	1459	specificity	specificity	NN	I-NP
O	1460	1463	for	for	IN	B-PP
O	1464	1472	oncogene	oncogene	NN	B-NP
O	1473	1483	activation	activation	NN	I-NP
O	1484	1490	during	during	IN	B-PP
O	1491	1493	in	in	FW	B-NP
O	1494	1499	vitro	vitro	FW	I-NP
O	1500	1503	rat	rat	NN	I-NP
B-Organ	1504	1511	bladder	bladder	NN	I-NP
O	1512	1526	transformation	transformation	NN	I-NP
O	1527	1536	initiated	initiate	VBN	B-VP
O	1537	1539	by	by	IN	B-PP
O	1540	1541	a	a	DT	B-NP
O	1542	1548	single	single	JJ	I-NP
O	1549	1559	carcinogen	carcinogen	NN	I-NP
O	1560	1563	and	and	CC	O
O	1564	1568	that	that	IN	B-SBAR
O	1569	1572	ras	ras	NN	B-NP
O	1573	1577	gene	gene	NN	I-NP
O	1578	1588	activation	activation	NN	I-NP
O	1589	1591	is	be	VBZ	B-VP
O	1592	1595	not	not	RB	O
O	1596	1597	a	a	DT	B-NP
O	1598	1607	necessary	necessary	JJ	I-NP
O	1608	1612	step	step	NN	I-NP
O	1613	1615	in	in	IN	B-PP
B-Cell	1616	1626	urothelial	urothelial	JJ	B-NP
O	1627	1641	transformation	transformation	NN	I-NP
O	1642	1644	in	in	FW	B-ADVP
O	1645	1650	vitro	vitro	FW	I-ADVP
O	1650	1651	.	.	.	O

